2025 · 1st Quarter (Jan 1 - Mar 31)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Literal source text
Issues related to mental health. Issues related to SUPPORT Act reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Monitored issues related to drug pricing. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Literal federal measure citations: H.R. 1968
Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Literal federal measure citations: H.R. 1968
H.R. 1990, the American Innovation and R&D Competitiveness Act, and issues related to the R&D tax credit. Issues related to the extension of the 2017 Tax Cut and Jobs Act provisions, and corporate and international taxes.
Literal federal measure citations: H.R. 1990
Issues related to litigation reform.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
